Jill D. Leversage's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 18,641 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 21, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharma Inc | Jill D. Leversage | Director | 21 Nov 2024 | 18,641 | 18,641 | - | - | Director Stock Option (right to buy) | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 21 Nov 2024 | 12,135 | 25,053 (0%) | 0% | 0 | Common Shares | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 21 May 2024 | 5,610 | 12,918 (0%) | 0% | 5.7 | 32,201 | Common Stock | |
| Aurinia Pharma Inc | Jill D. Leversage | Director | 18 May 2023 | 15,234 | 15,234 | - | - | Stock Option (right to buy) | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 18 May 2023 | 9,310 | 23,343 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 18 May 2023 | 8,733 | 14,033 (0%) | 0% | - | Common Stock | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 18 May 2023 | 8,733 | 0 | - | - | Restricted Stock Units | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 18 May 2023 | 4,815 | 18,528 (0%) | 0% | 11.3 | 54,217 | Common Stock | |
| Aurinia Pharma Inc | Jill D. Leversage | Director | 18 May 2022 | 14,612 | 14,612 | - | - | Stock Option (right to buy) | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 18 May 2022 | 8,733 | 8,733 | - | - | Restricted Stock Unit | ||
| Aurinia Pharma Inc | Jill D. Leversage | Director | 13 Dec 2021 | 1,600 | 5,300 (0%) | 0% | 20.0 | 32,064 | Common Stock |